Related Experiment Video
Updated: Jul 17, 2026
Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
NF-κB/AP-1-mediated expression of the porcine cathelicidin proPMAP-37 suppresses inflammation by neutralizing LPS and
Qingqing Fu1,2, Kunhong Xie1,2, Bing Yu1,2
1Institute of Animal Nutrition, Key Laboratory of Animal Disease-resistant Nutrition, Sichuan Agricultural University, Chengdu, Sichuan, 611130, People's Republic of China.
Background:
Cathelicidins are short cationic peptides secreted in pro-peptide, characterized by a conserved N-terminal cathelin domain and a diverse C-terminal mature peptide. While the antimicrobial and immunomodulatory properties of mature cathelicidins are well-characterized, whether their precursor forms (pro-forms) possess biological activity remains a subject of debate. Amid the global challenge of antimicrobial resistance (AMR) and the mandate to reduce antibiotic use in livestock, cathelicidins represent promising alternatives for managing bacterial infection in agriculture. However, high production costs hamper their large-scale application. Therefore, elucidating the regulation of expression of porcine myeloid antimicrobial peptide 37 (PMAP-37), investigating the function of its pro-form (proPMAP-37), and developing a cost-effective production strategy are of significant importance for both basic immunology in porcine systems and agricultural applications.
Results:
This study demonstrated that porcine myeloid antimicrobial peptide 37 (PMAP-37) exhibited widespread tissue distribution in disease-susceptible Duroc × Landrace × Yorkshire (DLY) pigs, whereas its constitutive expression level was significantly higher in disease-resistant Tibetan pigs (TB). Furthermore, Escherichia coli K88 (E. coli K88) upregulated PMAP-37 expression in the intestine of DLY pigs. Mechanistic investigations revealed that the induction of PMAP-37 mediated by E. coli K88 depends on NF-κB and AP-1 transcription factors. Importantly, proPMAP-37 (the precursor of PMAP-37) was successfully expressed in a heterologous system and purified to homogeneity. Functional characterization demonstrated negligible hemolytic activity and cytotoxicity toward mammalian cells. Although no direct bactericidal effect was observed in vitro, proPMAP-37 functioned as an immunomodulator. It exhibited high affinity with Lipopolysaccharide (LPS) and inhibited pro-inflammatory M1 macrophage polarization, thereby reducing the expression of interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α).
Conclusions:
This comprehensive study provides novel insights into the immunological functions of porcine cathelicidins and promotes the industrial development of proPMAP-37 as a novel anti-inflammatory agent.
